Elicio Therapeutics ELTX
NASDAQ ELTX
$1.82 +0.15 (+8.68%)
As of: Oct 22, 2026 · 11:00 AM EDT

Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021)

Updated

Elicio Therapeutics (ELTX) reported Gross Profit of $2.3 million for FY2022, down 91.7% from $27.88 million in FY2021.

Analysis

Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021) Analysis & Trends

  • According to Business Quant data, Gross Profit came in at $27.88 million in FY2021 and $1.69 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.06 Bn 1,139.65 Bn 19.71 Bn
2 Johnson & Johnson 634.89 Bn 553.42 Bn 17.26 Bn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn
4 Merck 377.44 Bn 331.82 Bn 12.21 Bn
5 Novartis Ag 303.91 Bn 267.90 Bn 11.24 Bn
6 Astrazeneca 267.03 Bn 240.72 Bn 12.86 Bn
7 Amgen 241.88 Bn 197.28 Bn 7.24 Bn
8 Gilead Sciences 194.01 Bn 168.20 Bn 6.22 Bn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn
10 Elicio Therapeutics 34.93 Mn -42.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 25.51 Mn
Sep 30, 2021 1.46 Mn
Jun 30, 2021 540,000.00
Mar 31, 2021 371,000.00
Dec 31, 2020 333,000.00
Sep 30, 2020 479,000.00
Jun 30, 2020 396,000.00
Mar 31, 2020 482,000.00
API Access

Elicio Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ELTX&period=max&api_key=YOUR_API_KEY